RT @CochraneSkin: A 2020 Cochrane Skin Review assessed the effects of interventions for all immunocompetent people who have American cutane…
A 2020 Cochrane Skin Review assessed the effects of interventions for all immunocompetent people who have American cutaneous and mucocutaneous leishmaniasis (ACML). Read more here: https://t.co/PaDWtb92TH https://t.co/JUmxzxFTZt
RT @CochraneSkin: The #CochraneSkin systematic review "Interventions for American cutaneous and mucocutaneous #leishmaniasis" included 75 s…
The #CochraneSkin systematic review "Interventions for American cutaneous and mucocutaneous #leishmaniasis" included 75 studies with over 6,500 randomized participants. Check out the blogshot and review below! Link: https://t.co/DOehnCZ3so #dermtwitter #de
RT @CochraneSkin: The #CochraneSkin systematic review "Interventions for American cutaneous and mucocutaneous #leishmaniasis" included 75 s…
RT @CochraneSkin: The #CochraneSkin systematic review "Interventions for American cutaneous and mucocutaneous #leishmaniasis" included 75 s…
The #CochraneSkin systematic review "Interventions for American cutaneous and mucocutaneous #leishmaniasis" included 75 studies with over 6,500 randomized participants. Check out the blogshot and review below! Link: https://t.co/DOehnCZ3so #dermtwitter #de
Artigo na @cochranecollab reavalia a eficácia e segurança dos antimoniais para tratamento das leishmanioses cutânea e mucocutânea americana em pessoas sem problemas imunológicos. Os estudos foram realizados, principalmente, nas Américas Central e do Sul 👉h
Artículo en @cochranecollab reevalúa la eficacia y la seguridad de los antimonias para el tratamiento de las leishmaniasis cutáneas y mucocutáneas americanas en personas sin problemas inmunológicos. Estudios, principalmente, en América Central y del Sur 👉
Interventions for American cutaneous and mucocutaneous leishmaniasis. Pinart M, Rueda J, Romero G, Pinzon-Florez C, Osorio-Arango K, Maia-Elkhoury A, Reveiz L, Elias V, Tweed J. #EHUpaper in Cochrane Database of Systematic Reviews https://t.co/pwGqdJ
RT @CochraneUK: What are the benefits and risks of different treatments for American (muco)cutaneous leishmaniasis (a parasitic disease of…
RT @CochraneUK: What are the benefits and risks of different treatments for American (muco)cutaneous leishmaniasis (a parasitic disease of…
RT @CochraneUK: What are the benefits and risks of different treatments for American (muco)cutaneous leishmaniasis (a parasitic disease of…
RT @Links_Medicus: Systematic review: Interventions for American cutaneous and mucocutaneous leishmaniasis – via @CochraneLibrary https://…
Systematic review: Interventions for American cutaneous and mucocutaneous leishmaniasis – via @CochraneLibrary https://t.co/cP1Io4eXIH
RT @CochraneLibrary: Interventions for American cutaneous and mucocutaneous leishmaniasis https://t.co/3DFXrAUOEc Updated systematic revie…
RT @CochraneLibrary: Interventions for American cutaneous and mucocutaneous leishmaniasis https://t.co/3DFXrAUOEc Updated systematic revie…
Interventions for American cutaneous and mucocutaneous leishmaniasis https://t.co/3DFXrAUOEc Updated systematic review includes 75 studies with 6533 randomised participants. #ACML is a disfiguring disease caused by parasites, transmitted to humans by sand
RT @CochraneUK: Interventions for American cutaneous & mucocutaneous leishmaniasis (ACML) https://t.co/dcizYgfwWO Updated systematic review…
RT @CochraneUK: Interventions for American cutaneous & mucocutaneous leishmaniasis (ACML) https://t.co/dcizYgfwWO Updated systematic review…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
RT @anthonywsolomon: The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americ…
The Cochrane review on management of cutaneous & mucocutaneous leishmaniasis in immunocompetent patients in the Americas has been updated: https://t.co/xaXEQsTT43. It firms💊miltefosine’s place as an option for CL due to L. braziliensis, L. guyanensis,